Llistar TÃtols
S'han trobat 54 Ãtems
Llistant Ãtems des de 50 a 54:
Format | Data | TÃtol | Autor |
---|
Format | Data | TÃtol | Autor |
|
|
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez MartÃn, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufà González, SÃlvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
5 juny 2018 |
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez MartÃn, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufà González, SÃlvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
2007 |
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review) |
Ferrer Soler, Laura
; Vázquez MartÃn, Alejandro
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
; Llorens Duran, Rafael de
; Colomer, Ramon
|
|
|
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review) |
Ferrer Soler, Laura
; Vázquez MartÃn, Alejandro
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
; Llorens Duran, Rafael de
; Colomer, Ramon
|